Deghinmotei Alfred-Ugbenbo

Dr. Deghinmotei Alfred-Ugbenbo

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2025
Verified
Book Chapter
Closed access
Odangowei OgidiOdangowei Ogidi
Odangowei Ogidi
DADeghinmotei Alfred-Ugbenbo
Deghinmotei Alfred-Ugbenbo
BPBlessing Elohor Poripo
Blessing Elohor Poripo
Conventional drug discovery frequently entails arduous and time-consuming procedures. Nevertheless, the emergence of artificial intelligence-based models presents new opportunities to accelerate the process of designing and developing innovative therapies. These models have multiple active applications in the therapeutic treatment of immunological disorders, such as autoimmune and autoinflammatory disorders (AIIDs). By integrating data from omic technologies and patient genetic profiling, the first models of rheumatoid arthritis, systemic lupus erythematosus, and primary Sjogren syndrome have been created in the last few years. The notion that a variety of AIIDs share a common molecular dysfunction and the validation of a complex pathophysiology that involves numerous proinflammatory pathways are both supported by these developments. Therefore this chapter discusses the utilisation of models in various applications, including the development of in silico drug candidates, the prediction of virtual patient efficacy, and the stratification of patients.

18 July 2017 in Medical and Clinical Chemistry
Verified
Journal Article
Closed access
PDF file
DADeghinmotei Alfred-Ugbenbo
Deghinmotei Alfred-Ugbenbo
Oleksandr ZdorykOleksandr Zdoryk
Oleksandr Zdoryk
VGV. A. Georgiyants
V. A. Georgiyants
Introduction. Extreme syrups can be manufactured using substances or ready medicinal drugs as the active pharmaceutical ingredient. There is a necessity in the development and validation of analytical methods that can be used for quality control of pharmaceutical manufacturing of syrups containing furosemide.The aim of the study – to develop and validate assay method for furosemide in extemporaneous syrups prepared from both pure substance and finished products. Methods of the research. For proposed UV spectrophotometric assay method the conditions of analysis, sample preparation and validation characteristics were defined. Suspensions of substance and crushed commercial tablets were dissolved in 0.1 M sodium hydroxide solution and evaluated spectrophotometrically in ultraviolet region of light at a wavelength 271 nm using method of specific absorbance.Results and Discussion. Samples comply with the Beer-Lambert Bouguer law within the concentration range of 8×10-3 – 1.2×10-2 mg/ml with correlation coefficients ≥ 0.9981. The uncertainty of the methods was well within the critical value of the error (0.72 %≤ maxΔAs) for both samples of syrup containing pure substance and commercial tablets. Recovery studies for furosemide in syrup samples of substance and crushed commercial tablets yielded 99.92 ±0.54 % and 99.14±0.16 % respectively. Assay limit of ±10 % by the validation parameters: specificity, linearity, precision, accuracy within the range of 80–120 % of the nominal contents was met by all compounded preparations.Conclusions. The results of validation proved that this method can be reproduced correctly and is suitable for use in pharmaceutical analysis. Adoption of this method is planned in evaluating uniformity of content and, in combination of other methods, ascertain chemical stability study of compounded furosemide syrups.

1 October 2023 in International Journal of Chemistry Research
Verified
Journal Article
Open access
PDF file
SBSAMUEL J BUNU
SAMUEL J BUNU
DGDorathy George
Dorathy George
DADeghinmotei Alfred-Ugbenbo
Deghinmotei Alfred-Ugbenbo
BEBenjamin U. Ebeshi
Benjamin U. Ebeshi
Objective: The study aimed to quantify the concentrations and carcinogenic-related health risks assessment of some heavy metals in selected energy drinks frequently utilized in Bayelsa State, Nigeria. Methods: Eleven energy drinks samples were purchased from the general markets in Amassoma and Yenagoa, Bayelsa State, Nigeria, and were labeled D1–D11. The samples were digested using 10 ml of nitric acid at 120-150 ℃, and 2 ml of Perchloric acid was added after attaining room temperature, it was digested further until a clear solution was obtained, then made up to 25 ml with distilled water. The concentration of lead, cadmium, iron, and zinc were determined and quantified using Atomic Absorption Spectrophotometry (AAS), and the health-associated risks of these metals were evaluated using the standard Target Health Quotient (THQ). Results: The EDI (Estimated Daily Intake) of lead (Pd), Cadmium (Cd), iron (Fe), and zinc (Zn) was 0.130, 0.001, 0.726, and 0.193 mg/l, respectively, all were within the World Health Organization (WHO)-acceptable range. The Chronic Daily Intake (CDI) of Pd, Cd, Fe, and Zn was obtained as 0.001 to 0.010, 5.7 x 10-5, 0.001 to 0.050, and 0.0001 to 0.010 mg/l respectively. Conclusion: THQ for all metals analyzed was<1, the WHO acceptable limit. All the heavy metals were within acceptable THQ limits, thus posing no carcinogenic health potential risks on long-term consumption.

31 October 2017 in ScienceRise: Pharmaceutical Science
Verified
Journal Article
Open access
PDF file
DADeghinmotei Alfred-Ugbenbo
Deghinmotei Alfred-Ugbenbo
Oleksandr ZdorykOleksandr Zdoryk
Oleksandr Zdoryk
VGViktoria Georgiyants
Viktoria Georgiyants
Оцінка якості та дослідження стабільності сиропу фуросеміду аптечного виготовлення

31 October 2022 in Turkish Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
MBMykola Yevstahiyovich Blazheyevskiy
Mykola Yevstahiyovich Blazheyevskiy
DADeghinmotei Alfred-Ugbenbo
Deghinmotei Alfred-Ugbenbo
OMOlena Mozgova
Olena Mozgova
VMValery Petrovich Moroz
Valery Petrovich Moroz
Objectives: To develop two (titrimetric and spectrophotometric) simple, rapid, sensitive and cost-effective methods for the determination of metoclopramide (MCP) in pharmaceutical dosage forms.Materials and Methods: The titrimetric method (A) was based on the N-oxidation reaction involving the use of potassium hydrogen peroxymonosulfate and subsequent iodometric back titration of a known residual reagent. The spectrophotometric method (B) was based on derivatization of MCP with potassium hydrogen peroxymonosulfate in the presence of iodide to produce a chromogen (triiodide) with a wavelength of maximum absorption at 350 nm.Results: Method "A" was applicable over the concentration range of 0.25-3.5 mg to end volume 10 mL. In method "B", Beer's law was obeyed over the concentration range of 0.3-3.5 mu g/mL with molar absorptivity of 24600 L/mol cm. The limits of quantification were calculated to be 0.25 mg/10 mL (A) and 0.2 mu g/mL (B), respectively.Conclusion: The proposed methods were suitable for determination of MCP as a pure substance in tablets and injection.

15 March 2016 in ScienceRise
Verified
Journal Article
Open access
PDF file
DADeghinmotei Alfred-Ugbenbo
Deghinmotei Alfred-Ugbenbo
Oleksandr ZdorykOleksandr Zdoryk
Oleksandr Zdoryk
VGViktoria Georgiyants
Viktoria Georgiyants
In the past decade the pharmacy practice worldwide has witness a trend shift from product-orientation to patient-orientation. This and other reasons encouraged the Nigerian government and its institutions to systematically de-emphasized through its budget, funding for the development of compounding unit. Aim: The aim of given article was to examine the challenges facing compounding pharmacists in hospital pharmacies, cost estimating of extemporaneous preparations and searching of solutions. Methods: A closed and open-ended format questionnaire was distributed to 50 compounding pharmacists in Rivers State of Nigeria. The questionnaire comprised of a cover letter and 10 items which cut across personnel training, staffing, premise and equipment, logistics, cost of compounding, national reference standards on compounding, in-pharmacy control. Results: From the survey results, challenges of compounding pharmacies in southern Nigeria such as inadequate manpower, absence of electronic documentation, facilities and funding; lack of national formulary on extemporaneous formulations and locally conducted stability tests were revealed. Cost of extemporaneous preparations ranged from 1–15 US dollars. Conclusions: Development and implementation of easily accessible national formulary on extemporaneous formulations and their stability study, development of standard operating procedures for all activities in the pharmacy and staff training on recent technologies in compounding preparations are recommended